Abstract
Goodpasture (GP) syndrome is a form of anti-glomerular basement membrane (GBM) disease, in which autoantibodies bind to α3(IV) collagen in GBM causing rapidly progressive glomerulonephritis and pulmonary hemorrhage. The conformational GP epitopes have been mapped to 2 regions within the noncollagenous (NC1) domain of the α3(IV) chain. Recently, we described the molecular organization of the autoantigen in the native α3α 4α5(IV) collagen network of the GBM. The crystal structure of the NC1 domain has revealed how the GP epitopes are sequestered in the native GBM. Further insight into the pathogenesis of disease has been obtained from better animal models. These advances provide a foundation for the development of new specific therapies.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 522-531 |
| Number of pages | 10 |
| Journal | Seminars in nephrology |
| Volume | 23 |
| Issue number | 6 |
| DOIs | |
| State | Published - Nov 2003 |
Funding
Supported in part by National Institutes of Health grants DK65123 (D.-B.B.), DK18381 and DK53763 (B.G.H.), DK46282 and DK55926 (E.G.N.), and the 2003 Carl Gottschalk Research Scholar Award from the American Society of Nephrology (D.-B.B.).
ASJC Scopus subject areas
- Nephrology